The Effects of a Digital Application for GDM Management in Improving Patients' Compliance

Sponsor
The Baruch Padeh Medical Center, Poriya (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05648721
Collaborator
Bar-Ilan University, Israel (Other)
110
4
2
15.4
27.5
1.8

Study Details

Study Description

Brief Summary

Gestational diabetes mellitus (GDM) is the most prevalent complication in pregnancy. Patients' follow-up and treatment is performed in specialized GDM clinics that teach and support women in implementing lifestyle changes, blood glucose self-monitoring, and nutritional and pharmacologic therapy.

Recently, mobile health (mHealth) applications have been introduced as a resource to improve self-management and follow-up among pregnant women. The proposed study will examine the efficacy of the GDM management mHealth application in improving patients' compliance and satisfaction, glycemic control, and pregnancy outcomes.

A multicenter randomized controlled trial of women with GDM treated in the GDM clinics. Women will be randomly allocated to a research group that will use the GDM application and a control group that will receive regular follow-up without the GDM application. The primary outcome is patient compliance, defined as the actual blood glucose measurements/instructed measurements ×100. Secondary outcomes include glycemic control parameters, and maternal and neonatal complications.

Condition or Disease Intervention/Treatment Phase
  • Other: Datos mobile health application
  • Other: Regular follow-up
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
110 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
The Effects of a Digital Application for Gestational Diabetes Management in Improving Patients' Compliance and Satisfaction, Glycemic Control and Pregnancy Outcomes: A Multicenter Randomized Controlled Trial
Anticipated Study Start Date :
Dec 20, 2022
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Apr 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mobile health application

Use of GDM application for GDM management

Other: Datos mobile health application
The mobile Health application will send women reminders to perform glucose tests and test results will be sent to the clinic personnel for evaluation. The clinic personnel will receive an alert if a woman does not send glucose charts or when there is an abnormality in the test results. In addition, women will be able to communicate with the clinic's personnel via chat, messages, phone calls, and video.

Other: Control

Regular follow-up without the GDM application

Other: Regular follow-up
Regular follow-up according to the local clinic protocol

Outcome Measures

Primary Outcome Measures

  1. Patient compliance [During the follow up in the clinic (around 4 months)]

    Defined as the actual blood glucose measurements/instructed measurements ×100

Secondary Outcome Measures

  1. Mean blood glucose of the daily glucose charts [During the follow up in the clinic (around 4 months)]

  2. Percentage of off-target glucose measurements [During the follow up in the clinic (around 4 months)]

  3. Need for pharmacotherapy for glycemic control [During the follow up in the clinic (around 4 months)]

  4. polyhydramnios [During the follow up in the clinic (around 4 months)]

    At least once

  5. Preeclampsia/gestational hypertension [During the follow up in the clinic (around 4 months)]

  6. Induction of labor [At birth]

  7. Instrumental or cesarean delivery [At birth]

  8. shoulder dystocia [At birth]

  9. Third- or fourth-degree perineal tears [At birth]

  10. Neonatal birth weight [At birth]

  11. Neonatal intensive care unit admission [A week after delivery]

  12. Hypoglycemia of the newborn [During hospitalization after delivery (around one week)]

  13. Respiratory morbidity of the newborn [During hospitalization after delivery (around one week)]

  14. Number of neonates who needed phototherapy [During hospitalization after delivery (around the first week)]

  15. Neonatal death [During hospitalization after delivery (around the first week)]

  16. Neonatal hypocalcemia [During hospitalization after delivery (around the first week)]

  17. Neonatal hypomagnesemia [During hospitalization after delivery (around the first week)]

  18. Apgar score [One and Five minutes after birth]

  19. Patients' satisfaction from the monitoring protocol [Will be evaluated up to 2 months after birth]

    According to numeric rating scale (1-least satisfied, 10-most satisfied)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Pregnant women diagnosed with GDM from 13.0 gestational week

  • Recruitment until 34.0 gestational week

  • 18 years old and older

  • Singleton pregnancy

Exclusion Criteria:
  • Women with pre-gestational diabetes mellitus

  • Multiple pregnancy

  • Women without a Smartphone that can support the GDM application

  • Refusal to participate

Contacts and Locations

Locations

Site City State Country Postal Code
1 Emek medical center Afula Israel
2 Rambam medical center Haifa Israel
3 Wolfson medical center H̱olon Israel
4 Galilee medical center Nahariya Israel

Sponsors and Collaborators

  • The Baruch Padeh Medical Center, Poriya
  • Bar-Ilan University, Israel

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
The Baruch Padeh Medical Center, Poriya
ClinicalTrials.gov Identifier:
NCT05648721
Other Study ID Numbers:
  • 56-22-POR
First Posted:
Dec 13, 2022
Last Update Posted:
Dec 13, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by The Baruch Padeh Medical Center, Poriya
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 13, 2022